Effect of dapagliflozin on cardiovascular outcomes in patients with type 2 diabetes according to baseline renal function and albuminuria status: Insights from DECLARE-TIMI 58

Collapse authors list.
Zelniker, TA, Raz, I, Mosenzon, O, Dwyer, JP, Heerspink, HJL, Cahn, A, Im, K, Bhatt, DL, Leiter, LA, McGuire, DK et al (show 5 more authors) , Wilding, JPH ORCID: 0000-0003-2839-8404, Gause-Nilsson, IAM, Langkilde, AM, Sabatine, MS and Wiviott, SD (2019) Effect of dapagliflozin on cardiovascular outcomes in patients with type 2 diabetes according to baseline renal function and albuminuria status: Insights from DECLARE-TIMI 58. .

Text Zelniker ESC abstract DECLARE renal 2019.docx - Author Accepted Manuscript Download (69kB)